Journal article icon

Journal article

Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine.

Abstract:

RATIONALE: Throughout our lives we constantly assess the costs and benefits of the possible future outcomes of our actions and use this information to guide behavior. There is accumulating evidence that dopamine contributes to a fundamental component of this computation-how rewards are compared with the costs incurred when obtaining them. OBJECTIVE: We review the evidence for dopamine's role in cost-benefit decision making and outline a simple mathematical framework in which to represent the ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1007/s00213-006-0626-6

Authors


Phillips, PE More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Experimental Psychology
Journal:
Psychopharmacology
Volume:
191
Issue:
3
Pages:
483-495
Publication date:
2007-04-05
DOI:
EISSN:
1432-2072
ISSN:
0033-3158
URN:
uuid:c84e960e-4811-4555-9e8f-84429bed3189
Source identifiers:
240837
Local pid:
pubs:240837

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP